These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3623)

  • 21. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine.
    Sherwood M; Thornton AE; Honer WG
    J Psychopharmacol; 2012 Sep; 26(9):1175-84. PubMed ID: 22465946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Delayed-action neuroleptics and maintenance treatments].
    Péron-Magnan P
    Encephale; 1991; 17(4):263-6. PubMed ID: 1683627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of antipsychotic drugs.
    Osser DN; Akhter A
    Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853
    [No Abstract]   [Full Text] [Related]  

  • 27. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
    Welbel L
    Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774
    [No Abstract]   [Full Text] [Related]  

  • 28. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D2 antagonist augmentation in patients with a partial response to atypical antipsychotics.
    Mazeh D; Melamed Y; Weizman A
    Can J Psychiatry; 2004 Apr; 49(4):281-2. PubMed ID: 15147030
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient.
    Hung GC; Chen YY
    J Psychopharmacol; 2009 Jan; 23(1):106-8. PubMed ID: 18308778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks of intermittent antipsychotic treatment in schizophrenia.
    Suzuki T; Nomura K; Watanabe K
    J Clin Psychiatry; 2011 Jan; 72(1):114; author reply 114-5. PubMed ID: 21272519
    [No Abstract]   [Full Text] [Related]  

  • 32. New generation versus conventional antipsychotics.
    Geddes J; Harrison P; Freemantle N
    Lancet; 2003 Aug; 362(9381):404; author reply 404-5. PubMed ID: 12907021
    [No Abstract]   [Full Text] [Related]  

  • 33. [The maintenance dosage of neuroleptic agents].
    Stolk PJ
    Ned Tijdschr Geneeskd; 1987 Jul; 131(27):1158-9. PubMed ID: 2886929
    [No Abstract]   [Full Text] [Related]  

  • 34. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.
    Kinon BJ; Chen L; Ascher-Svanum H; Stauffer VL; Kollack-Walker S; Sniadecki JL; Kane JM
    Schizophr Res; 2008 Jul; 102(1-3):230-40. PubMed ID: 18423985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.
    Harvey PD; Keefe RS
    Am J Psychiatry; 2001 Feb; 158(2):176-84. PubMed ID: 11156796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.
    Smith RC
    Arch Gen Psychiatry; 1994 May; 51(5):427-9. PubMed ID: 7910013
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose antipsychotic medication.
    Bennie EH
    Br J Psychiatry; 1994 Oct; 165(4):553. PubMed ID: 7528625
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effectiveness of antipsychotic drugs.
    Gupta S
    Am J Psychiatry; 2003 Mar; 160(3):591; author reply 592-3. PubMed ID: 12611855
    [No Abstract]   [Full Text] [Related]  

  • 39. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic drug monitoring of atypical antipsychotic drugs.
    Grundmann M; Kacirova I; Urinovska R
    Acta Pharm; 2014 Dec; 64(4):387-401. PubMed ID: 25531781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.